- Poster presentation
- Open Access
P19 - Assessment of quality of life in Uruguayan children with atopic eczema and their families
© Ale et al; licensee BioMed Central Ltd. 2014
Published: 28 February 2014
Skin diseases produce a negative impact on the psycho-emotional state, social relationships and daily activities. This effect should be particularly important during childhood, a critical period for physical and psychosocial development. However, there is a scarcity of publications on the impact of dermatological diseases in the pediatric population.
Atopic eczema (AE) is a chronic eczematous and pruritic skin disease that may affect the physical, social, and emotional functioning of the affected children as well as their families.
One hundred and twenty children (69 females and 51 males) from 6 months to 14 years old, attending the Department of Dermatology at the Pediatric University Hospital in Montevideo, Uruguay, with a confirmed diagnosis of AE -according to the criteria of Hanifin and Rajka- and their parents, entered the study. As a control group we included 100 healthy children of comparable age, gender and socioeconomic background, as well as their parents. The data collection instruments were the Children's Dermatology Life Quality Index (CDLQI), the Infant's Dermatitis Quality of Life Index (IDQOL) and the Dermatitis Family Impact Questionnaire (DFI). Severity of AE was assessed with the SCORAD.
The median score for the IDQOL was 8.92 (range 2-23, n=66), for the CDLQI, 10.84 (0-26, n=54), and for the DFI, 8.17 (4-25. n=120). All these values were significantly different from the control subjects. There was no significant gender difference.
The results show that AE significantly impairs the children's quality of life in all age groups and also the quality of life of their families. We suggest the regular evaluation of the quality of life in the clinical management of children with AE.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.